Momelotinib in VEXAS Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
- Status
- RECRUITING
- Phase
- PHASE1
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months
- Status
- RECRUITING
- Phase
- PHASE2
Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- Status
- RECRUITING
- Phase
- PHASE3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- Status
- RECRUITING
- Phase
- PHASE3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- Status
- RECRUITING
- Phase
- PHASE3
All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- Status
- RECRUITING
- Phase
- PHASE2
Eosinophil Subpopulations in Eosinophilic-associated Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4